Cover Image
Market Research Report

Asia Pacific Smart Inhalers Market Forecast 2019-2028

Published by Inkwood Research Product code 945449
Published Content info 133 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Smart Inhalers Market Forecast 2019-2028
Published: June 30, 2020 Content info: 133 Pages
Description

KEY FINDINGS

The Asia Pacific smart inhalers market is expected to grow at a CAGR of 32.25%, across the forecast period of 2019 to 2028. The key factors driving market growth in this region are an increase in disposable income, awareness related to the benefits of using smart inhalers, and the rapid development of medical infrastructure.

MARKET INSIGHTS

China, Japan, India, Indonesia, South Korea, Thailand, Vietnam, Australia & New Zealand, and the rest of Asia Pacific are studied for the Asia Pacific smart inhalers market growth analysis. Widespread and highly prevalent respiratory chronic conditions in South Korea include asthma, Chronic Obstructive Pulmonary Disease (COPD), allergic rhinitis, and rhinosinusitis. The rising aging population and healthcare reforms like the acceleration of basic medical insurance and reimbursement systems are among the factors facilitating the smart inhalers market growth. Moreover, high imports from developed markets, incorporated with a good economic relationship with Europe is expected to fuel the market growth and demand in the country.

Several initiatives on increasing awareness about respiratory conditions are being introduced in Thailand. However, there is limited accessibility to long-term disease management resources, and social stigma causing underdiagnosis and inadequate medical treatment options available in the country. As a result, the market for smart inhalers in Thailand is estimated to be stable, across the forecast period. Additionally, an upsurge in respiratory infections in countries like Indonesia and China are anticipated to drive the market growth in the region.

COMPETITIVE INSIGHTS

3M Company, Agilent Technologies Inc, AstraZeneca PLC, Novartis AG, Cohero Health Inc, etc. are among the renowned companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32378

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN AIR POLLUTION
    • 3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
    • 3.2.3. SURGING INDOOR AIR POLLUTANTS
    • 3.2.4. RISING GERIATRIC POPULATION
    • 3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
  • 3.3. KEY RESTRAINTS
    • 3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
    • 3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. EVOLUTION OF SMART INHALERS
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SMART INHALERS
  • 5.2. SMART NEBULIZER
    • 5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
      • 5.2.1.1. PNEUMATIC NEBULIZER
      • 5.2.1.2. ULTRASONIC NEBULIZER
      • 5.2.1.3. MESH NEBULIZER
    • 5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
      • 5.2.2.1. TABLETOP NEBULIZER
      • 5.2.2.2. PORTABLE NEBULIZER
    • 5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
      • 5.2.3.1. DIRECT PURCHASE
      • 5.2.3.2. ONLINE PURCHASE

6. MARKET BY INDICATION

  • 6.1. ASTHMA
  • 6.2. COPD

7. MARKET BY DISTRIBUTION CHANNEL

  • 7.1. HOSPITAL
  • 7.2. PHARMACY

8. GEOGRAPHICAL ANALYSIS

  • 8.1. ASIA PACIFIC
    • 8.1.1. JAPAN
    • 8.1.2. CHINA
    • 8.1.3. INDIA
    • 8.1.4. AUSTRALIA & NEW ZEALAND
    • 8.1.5. SOUTH KOREA
    • 8.1.6. THAILAND
    • 8.1.7. INDONESIA
    • 8.1.8. VIETNAM
    • 8.1.9. REST OF ASIA PACIFIC

9. COMPANY PROFILES

  • 9.1. 3M COMPANY
  • 9.2. ADHERIUM LIMITED
  • 9.3. AGILENT TECHNOLOGIES INC
  • 9.4. ASTRAZENECA PLC
  • 9.5. BOEHRINGER INGELHEIM GMBH
  • 9.6. COHERO HEALTH INC
  • 9.7. GLAXOSMITHKLINE PLC
  • 9.8. KONINKLIJKE PHILIPS NV
  • 9.9. NOVARTIS AG
  • 9.10. OPKO HEALTH INC
  • 9.11. RESMED INC (PROPELLER HEALTH)
  • 9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • 9.13. VECTURA GROUP PLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SMART INHALERS
  • TABLE 2: ASIA PACIFIC SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 3: ASIA PACIFIC SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 4: ASIA PACIFIC SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 5: ASIA PACIFIC SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 6: ASIA PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 7: ASIA PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS 2019-2028 (IN $ THOUSAND)
  • TABLE 8: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 9: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: ASIA PACIFIC SMART INHALERS MARKET, BY PRODUCT, IN 2019
  • FIGURE 6: ASIA PACIFIC SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)
  • FIGURE 7: ASIA PACIFIC SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 8: ASIA PACIFIC SMART INHALERS MARKET, BY INDICATION, IN 2019
  • FIGURE 9: ASIA PACIFIC SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)
  • FIGURE 10: ASIA PACIFIC SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)
  • FIGURE 11: ASIA PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 12: ASIA PACIFIC SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)
  • FIGURE 13: ASIA PACIFIC SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)
  • FIGURE 14: ASIA PACIFIC SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: JAPAN SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 16: CHINA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 17: INDIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 18: AUSTRALIA & NEW ZEALAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 19: SOUTH KOREA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 20: THAILAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 21: INDONESIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 22: VIETNAM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 23: REST OF ASIA PACIFIC SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
Back to Top